BiotechTube

ciclesonide nasal aerosol + Placebo

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Perennial Allergic Rhinitis

Conditions

Perennial Allergic Rhinitis, PAR

Trial Timeline

Jul 1, 2011 โ†’ Nov 1, 2011

NCT ID
NCT01378429

About ciclesonide nasal aerosol + Placebo

ciclesonide nasal aerosol + Placebo is a phase 3 stage product being developed by Sumitomo Pharma for Perennial Allergic Rhinitis. The current trial status is completed. This product is registered under clinical trial identifier NCT01378429. Target conditions include Perennial Allergic Rhinitis, PAR.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01378429Phase 3Completed

Competing Products

20 competing products in Perennial Allergic Rhinitis

See all competitors
ProductCompanyStageHype Score
LY3650150 + Placebo + Standard therapy for INCSEli LillyPhase 3
77
ciclesonide nasal aerosol + ciclesonide nasal spraySumitomo PharmaApproved
85
ciclesonide hydrofluoroalkane (HFA) nasal aerosol + mometasone nasal inhalationSumitomo PharmaPhase 3
77
ciclesonide + mometasoneSumitomo PharmaPhase 3
77
Ciclesonide HFA Nasal Aerosol 320 mcg + Ciclesonide HFA Nasal Aerosol 160 mcg + HFA Nasal Aerosol placebo + Ciclesonide Aqueous Nasal Spray 200 mcg + AQ Nasal Spray Placebo + Placebo plus Dexamethasone HFA + Placebo AQ plus Dexamethasone 6 mgSumitomo PharmaPhase 3
77
Ciclesonide nasal aerosol 37 mcg + ciclesonide nasal aerosol 74 mcg + PlaceboSumitomo PharmaPhase 3
77
ciclesonide HFA 160 ฮผgSumitomo PharmaPhase 3
77
Budesonide + PlaceboAstraZenecaApproved
85
Ciclesonide + PlaceboAstraZenecaPhase 3
77
CiclesonideAstraZenecaPhase 3
77
CiclesonideAstraZenecaPhase 3
77
Ciclesonide nasal + PlaceboAstraZenecaPhase 3
77
Ciclesonide + PlaceboAstraZenecaPhase 3
77
Ciclesonide nasal spray + placebo Azelastine + Ciclesonide nasal spray + AzelastineAstraZenecaApproved
85
CiclesonideAstraZenecaPhase 3
77
MK-8237 tablets + Placebo tablets + Rescue Medication: Self-Injectable Epinephrine + Rescue Medication: Loratadine tablets + Rescue Medication: Olopatadine ophthalmic drops + Rescue Medication: Mometasone furoate nasal sprayMerckPhase 3
77
Placebo + Montelukast + Fluticasone propionateMerckApproved
85
montelukast + placeboMerckApproved
85
MK-8237 6 DU + MK-8237 12 DU + PlaceboMerckPhase 1
33
loratadine + loratadine + loratadineMerckApproved
85

Other Products from Sumitomo Pharma

BlonanserinApproved
85
Mosapride + domperidoneApproved
85
levalbuterol HCl + albuterol SulfateApproved
85
LurasidoneApproved
85
placebo, isotonic ciclesonide, hypotonic ciclesonideApproved
85